MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 2 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,894 | -86.2% | 294,405 | -64.1% | 0.00% | -100.0% |
| Q2 2023 | $2,700,064 | -10.0% | 820,688 | +12.5% | 0.00% | 0.0% |
| Q1 2023 | $2,998,948 | -23.7% | 729,671 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $3,932,218 | -9.6% | 671,027 | +4.3% | 0.00% | -50.0% |
| Q3 2022 | $4,352,000 | +43.5% | 643,645 | -1.9% | 0.00% | +100.0% |
| Q2 2022 | $3,032,000 | +63.5% | 656,164 | +41.2% | 0.00% | 0.0% |
| Q1 2022 | $1,854,000 | -38.9% | 464,660 | -4.8% | 0.00% | 0.0% |
| Q4 2021 | $3,036,000 | -33.3% | 488,005 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $4,549,000 | -18.8% | 482,310 | +16.9% | 0.00% | -50.0% |
| Q2 2021 | $5,602,000 | -6.5% | 412,473 | +11.4% | 0.00% | 0.0% |
| Q1 2021 | $5,990,000 | -37.2% | 370,183 | +3.3% | 0.00% | -50.0% |
| Q4 2020 | $9,534,000 | +44.8% | 358,252 | +1.4% | 0.00% | +33.3% |
| Q3 2020 | $6,582,000 | +136.9% | 353,475 | +197.8% | 0.00% | +200.0% |
| Q2 2020 | $2,778,000 | +453.4% | 118,689 | +37.8% | 0.00% | – |
| Q1 2020 | $502,000 | +2.9% | 86,105 | +1.2% | 0.00% | – |
| Q4 2019 | $488,000 | +261.5% | 85,045 | 0.0% | 0.00% | – |
| Q3 2019 | $135,000 | -60.9% | 85,045 | 0.0% | 0.00% | – |
| Q2 2019 | $345,000 | +87.5% | 85,045 | +144.0% | 0.00% | – |
| Q1 2019 | $184,000 | +84.0% | 34,850 | +42.2% | 0.00% | – |
| Q4 2018 | $100,000 | -64.4% | 24,500 | -12.8% | 0.00% | – |
| Q3 2018 | $281,000 | -35.8% | 28,100 | +14.7% | 0.00% | – |
| Q2 2018 | $438,000 | +36.4% | 24,500 | +20.7% | 0.00% | – |
| Q1 2018 | $321,000 | – | 20,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
| Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
| Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
| Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
| Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
| DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |